Skip to main content
Top
Published in: BMC Psychiatry 1/2016

Open Access 01-12-2016 | Research article

Do routine outcome monitoring results translate to clinical practice? A cross-sectional study in patients with a psychotic disorder

Authors: Magda Tasma, Marte Swart, Gert Wolters, Edith Liemburg, Richard Bruggeman, Henderikus Knegtering, Stynke Castelein

Published in: BMC Psychiatry | Issue 1/2016

Login to get access

Abstract

Background

The use of Routine Outcome Monitoring (ROM) in mental health care has increased widely during the past decade. Little is known, however, on the implementation and applicability of ROM outcome in daily clinical practice. In the Netherlands, an extensive ROM-protocol for patients with psychotic disorders has been implemented over the last years (ROM-Phamous). The current study investigated to what extent ROM results translate to daily clinical practice. Therefore, we investigated whether clinical problems as identified with ROM were detected and used in the treatment of patients with psychotic disorders.

Methods

Out of the ROM database of 2010 (n = 1040), a random sample of 100 patients diagnosed with a psychotic disorder was drawn. ROM-data used in this study included a physical examination, laboratory tests, interviews and self-report questionnaires. Based on these data, the prevalence of positive and negative symptoms, psychosocial problems and cardiovascular risk factors was determined. Next, we investigated whether these problems, as identified with ROM, were reflected in the treatment plans of patients, as an indication of the use of ROM in clinical practice.

Results

The sample consisted of 63 males and 37 females. The mean age was 44 and the mean duration of illness was 17.7 years. The prevalence of positive and negative symptoms, psychosocial problems and cardiovascular risk factors ranged from 11 to 86 %. In the majority of cases, problems as identified with ROM were not reflected in the treatment plans of patients.

Conclusions

We found a substantial discrepancy between the ROM measurements and the treatment plans, i.e. low rates of detection of symptoms, psychosocial problems and cardiovascular risk factors in the treatment plans, even though these problems were identified with ROM. The opposite occurred as well, where problems were reflected in the treatment plans but not identified with ROM. Thus, ROM and daily clinical practice appear to be two separate processes, whereas ideally they should be integrated. Strong efforts should be made to integrate ROM and consequent treatment activities. Such integration may help to provide patients with adequate and customized care and simultaneously minimize under- and over-treatment.
Literature
1.
go back to reference American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington: American Psychiatric Publisher; 2000. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington: American Psychiatric Publisher; 2000.
2.
go back to reference Cahn W, Krabbendam L, Myin-Germeys I, Bruggeman R, De Haan L. Diagnostiek van het psychiatrische toestandsbeeld (Dutch). Handboek Schizofrenie (Dutch). 1st ed. Utrecht: De Tijdstroom Uitgeverij; 2011. p. 62–3. Cahn W, Krabbendam L, Myin-Germeys I, Bruggeman R, De Haan L. Diagnostiek van het psychiatrische toestandsbeeld (Dutch). Handboek Schizofrenie (Dutch). 1st ed. Utrecht: De Tijdstroom Uitgeverij; 2011. p. 62–3.
3.
go back to reference Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci. 2000;250(6):274–85.CrossRefPubMed Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci. 2000;250(6):274–85.CrossRefPubMed
4.
go back to reference Thornicroft G, Tansella M, Becker T, Knapp M, Leese M, Schene A, et al. The personal impact of schizophrenia in Europe. Schizophr Res. 2004;69(2–3):125–32.CrossRefPubMed Thornicroft G, Tansella M, Becker T, Knapp M, Leese M, Schene A, et al. The personal impact of schizophrenia in Europe. Schizophr Res. 2004;69(2–3):125–32.CrossRefPubMed
5.
go back to reference Pinikahana J, Happell B, Hope J, Keks NA. Quality of life in schizophrenia: a review of the literature from 1995 to 2000. Int J Ment Health Nurs. 2002;11(2):103–11.CrossRefPubMed Pinikahana J, Happell B, Hope J, Keks NA. Quality of life in schizophrenia: a review of the literature from 1995 to 2000. Int J Ment Health Nurs. 2002;11(2):103–11.CrossRefPubMed
6.
7.
go back to reference De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24(6):412–24.CrossRefPubMed De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24(6):412–24.CrossRefPubMed
8.
go back to reference Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620–7.CrossRefPubMed Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620–7.CrossRefPubMed
9.
go back to reference Weinmann S, Read J, Aderhold V. Influence of antipsychotics on mortality in schizophrenia: systematic review. Schizophr Res. 2009;113(1):1–11.CrossRefPubMed Weinmann S, Read J, Aderhold V. Influence of antipsychotics on mortality in schizophrenia: systematic review. Schizophr Res. 2009;113(1):1–11.CrossRefPubMed
10.
go back to reference Meyer JM. Treating the mind and body in schizophrenia: risks and prevention. CNS Spectr. 2004;9(10 Suppl 11):25–33.PubMed Meyer JM. Treating the mind and body in schizophrenia: risks and prevention. CNS Spectr. 2004;9(10 Suppl 11):25–33.PubMed
11.
go back to reference Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry. 2008;69(4):514–9.CrossRefPubMed Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry. 2008;69(4):514–9.CrossRefPubMed
12.
go back to reference DE Hert M, Schreurs V, Vancampfort D, VAN Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009;8(1):15–22.CrossRef DE Hert M, Schreurs V, Vancampfort D, VAN Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009;8(1):15–22.CrossRef
13.
go back to reference Cradock-O'Leary J, Young AS, Yano EM, Wang M, Lee ML. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv. 2002;53(7):874–8.CrossRefPubMed Cradock-O'Leary J, Young AS, Yano EM, Wang M, Lee ML. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv. 2002;53(7):874–8.CrossRefPubMed
14.
go back to reference Carlier IV, Meuldijk D, van Vliet IM, van Fenema EM, van der Wee NJ, Zitman FG. Empirical evidence for the effectiveness of Routine Outcome Monitoring. A study of the literature. Tijdschr Psychiatr. 2012;54(2):121–8.PubMed Carlier IV, Meuldijk D, van Vliet IM, van Fenema EM, van der Wee NJ, Zitman FG. Empirical evidence for the effectiveness of Routine Outcome Monitoring. A study of the literature. Tijdschr Psychiatr. 2012;54(2):121–8.PubMed
15.
go back to reference Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry. 2002;180:101–3.CrossRefPubMed Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry. 2002;180:101–3.CrossRefPubMed
16.
go back to reference Zimmerman M, McGlinchey JB. Why don’t psychiatrists use scales to measure outcome when treating depressed patients? J Clin Psychiatry. 2008;69(12):1916–9.CrossRefPubMed Zimmerman M, McGlinchey JB. Why don’t psychiatrists use scales to measure outcome when treating depressed patients? J Clin Psychiatry. 2008;69(12):1916–9.CrossRefPubMed
17.
go back to reference Laane R, Luijk R. ROM and the position of the health insurance companies. Tijdschr Psychiatr. 2012;54(2):135–9.PubMed Laane R, Luijk R. ROM and the position of the health insurance companies. Tijdschr Psychiatr. 2012;54(2):135–9.PubMed
19.
go back to reference Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRefPubMed Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.CrossRefPubMed
20.
go back to reference Wing JK, Beevor AS, Curtis RH, Park SB, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry. 1998;172:11–8.CrossRefPubMed Wing JK, Beevor AS, Curtis RH, Park SB, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry. 1998;172:11–8.CrossRefPubMed
21.
go back to reference Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry. 1999;45(1):7–12.CrossRefPubMed Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry. 1999;45(1):7–12.CrossRefPubMed
22.
go back to reference Lako IM, Bruggeman R, Liemburg EJ, van den Heuvel ER, Knegtering H, Slooff CJ, et al. A brief version of the Subjects’ Response to Antipsychotics questionnaire to evaluate treatment effects. Schizophr Res. 2013;147(1):175–80.CrossRefPubMed Lako IM, Bruggeman R, Liemburg EJ, van den Heuvel ER, Knegtering H, Slooff CJ, et al. A brief version of the Subjects’ Response to Antipsychotics questionnaire to evaluate treatment effects. Schizophr Res. 2013;147(1):175–80.CrossRefPubMed
23.
go back to reference IBM Corp. IBM SPSS Statistics for Windows. 2011;20. IBM Corp. IBM SPSS Statistics for Windows. 2011;20.
24.
go back to reference Andreasen NC, Carpenter Jr WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441–9.CrossRefPubMed Andreasen NC, Carpenter Jr WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441–9.CrossRefPubMed
25.
go back to reference Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007;116(5):317–33.CrossRefPubMed Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007;116(5):317–33.CrossRefPubMed
26.
go back to reference Stinckens N, Smits D, Claes L, Soenen S. Meaningful ‘romming’ (routine outcome monitoring): seeking a balance between userfriendliness and clinical relevance. Tijdschr Psychiatr. 2012;54(2):161–5.PubMed Stinckens N, Smits D, Claes L, Soenen S. Meaningful ‘romming’ (routine outcome monitoring): seeking a balance between userfriendliness and clinical relevance. Tijdschr Psychiatr. 2012;54(2):161–5.PubMed
27.
go back to reference Hatfield DR, Ogles BM. Why some clinicians use outcome measures and others do not. Adm Policy Ment Health. 2007;34(3):283–91.CrossRefPubMed Hatfield DR, Ogles BM. Why some clinicians use outcome measures and others do not. Adm Policy Ment Health. 2007;34(3):283–91.CrossRefPubMed
28.
go back to reference Boswell JF, Kraus DR, Miller SD, Lambert MJ. Implementing routine outcome monitoring in clinical practice: Benefits, challenges, and solutions. Psychother Res. 2013;26:1–14. Boswell JF, Kraus DR, Miller SD, Lambert MJ. Implementing routine outcome monitoring in clinical practice: Benefits, challenges, and solutions. Psychother Res. 2013;26:1–14.
29.
go back to reference de Jong K. The role of the therapist: the ‘forgotten’ factor in ROM. Tijdschr Psychiatr. 2012;54(2):197–201.PubMed de Jong K. The role of the therapist: the ‘forgotten’ factor in ROM. Tijdschr Psychiatr. 2012;54(2):197–201.PubMed
Metadata
Title
Do routine outcome monitoring results translate to clinical practice? A cross-sectional study in patients with a psychotic disorder
Authors
Magda Tasma
Marte Swart
Gert Wolters
Edith Liemburg
Richard Bruggeman
Henderikus Knegtering
Stynke Castelein
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-016-0817-6

Other articles of this Issue 1/2016

BMC Psychiatry 1/2016 Go to the issue